Share This Article
Chip designer Arm has been granted a patent for a headset system that fights XR motion sickness by sending ultrasound pulses to the wearer’s inner ear. The filing, “Method for minimising motion sickness for head-mountable extended reality,” was submitted in the US in July 2023 and granted in June 2026.
The mismatch between sight and balance is the target. Arm’s design compares the motion in frames bound for the display against a threshold, and when the gap grows too large, onboard circuitry drives ultrasonic transducers that push back on the vestibular system. A gentle drift of the virtual world to the left would arrive with a faint nudge in the same direction, and the push would intensify as the scene’s motion accelerates. The filing centers on low-intensity focused ultrasound, or LiFU, and mentions transducer arrays, one or more per ear, that could beamform onto specific inner-ear regions.
Ultrasound is one lever among several in the filing. Arm also sketches softer interventions, like trimming visual motion, dimming the frame, adding a vignette, or syncing on-screen movement to how the wearer actually moves. Stimulation could be tuned to the wearer’s pose, saved preferences, and live sensor data, with recalibration when the sensed motion stops matching the visuals.
Arm’s designs sit inside most smartphone and XR processors, so the patent hints at future reference designs rather than consumer hardware. Electrical stimulation has been floated before, but no shipping XR device includes direct vestibular stimulation yet, and a patent is not proof a product will appear.
Source: Road to VR


